Pfizer has ended its large Phase III Trial of an updated COVID19 vaccine. They were not able to enroll enough people to meet their goal. A major problem is the FDA’s wholly unreasonable demand that people with chronic conditions, who benefit most from the vaccine, not be allowed to participate.